Kwas dokozaheksaenowy (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kwas dokozaheksaenowy" in Polish language version.

refsWebsite
Global rank Polish rank
2nd place
6th place
4th place
7th place
5th place
2nd place
low place
5,916th place
low place
585th place
1st place
1st place
1,544th place
1,426th place

doi.org

dx.doi.org

  • Usha Ramakrishnan i inni, Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial1, „The American Journal of Clinical Nutrition”, 104 (4), 2016, s. 1075–1082, DOI10.3945/ajcn.114.101071, ISSN 0002-9165, PMID27604770, PMCIDPMC5039806 [dostęp 2018-07-10].
  • Puneet Anand, Ankur Sachdeva, Effect of Poly Unsaturated Fatty Acids Administration on Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial, „Journal of Clinical and Diagnostic Research : JCDR”, 10 (9), 2016, OC01–OC05, DOI10.7860/JCDR/2016/20423.8471, ISSN 2249-782X, PMID27790483, PMCIDPMC5071983 [dostęp 2018-07-10].
  • Xiang Li i inni, Docosahexanoic Acid-Induced Coronary Arterial Dilation: Actions of 17S-Hydroxy Docosahexanoic Acid on K+ Channel Activity, „The Journal of Pharmacology and Experimental Therapeutics”, 336 (3), 2011, s. 891–899, DOI10.1124/jpet.110.176461, ISSN 0022-3565, PMID21156816, PMCIDPMC3061543 [dostęp 2018-07-10].
  • Timothy J. Key i inni, Long-chain n–3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men, „The American Journal of Clinical Nutrition”, 82 (2), 2005, s. 327–334, DOI10.1093/ajcn/82.2.327, PMID16087975 (ang.).
  • Gregory A Jicha, William R Markesbery, Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease, „Clinical Interventions in Aging”, 5, 2010, s. 45–61, DOI10.2147/cia.s5231, ISSN 1176-9092, PMID20396634, PMCIDPMC2854051 [dostęp 2018-07-10].

doi.org

  • publikacja w otwartym dostępie – możesz ją przeczytać K.M. Appleton, R.C. Hayward, D. Gunnell, T.J. Peters i inni. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. „Am J Clin Nutr”. 84 (6), s. 1308–1316, 2006. DOI: 10.1093/ajcn/84.6.1308. PMID: 17158410. 
  • publikacja w otwartym dostępie – możesz ją przeczytać P.J. Rogers, K.M. Appleton, D. Kessler, T.J. Peters i inni. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. „Br J Nutr”. 99 (2), s. 421–431, 2008. DOI: 10.1017/S0007114507801097. PMID: 17956647. 
  • publikacja w otwartym dostępie – możesz ją przeczytać A.J. Richardson. n-3 Fatty acids and mood: the devil is in the detail. „Br J Nutr”. 99 (2), s. 221–223, 2008. DOI: 10.1017/S0007114507824123. PMID: 17919344. 
  • publikacja w otwartym dostępie – możesz ją przeczytać J. Zhang, Y. Li. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial–comments by Zhang and Li. „Br J Nutr”. 100 (6), s. 1347–1348, 2008. DOI: 10.1017/S0007114508975644. PMID: 18768099. 
  • publikacja w otwartym dostępie – możesz ją przeczytać P.J. Rogers, K.M. Appleton, D. Kessler, T.J. Peters i inni. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial – reply by Rogers et al.. „Br J Nutr”. 99 (2), s. 421–431, 2008. DOI: 10.1017/S0007114508975656. 

ncez.pl

nih.gov

ncbi.nlm.nih.gov

  • Usha Ramakrishnan i inni, Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial1, „The American Journal of Clinical Nutrition”, 104 (4), 2016, s. 1075–1082, DOI10.3945/ajcn.114.101071, ISSN 0002-9165, PMID27604770, PMCIDPMC5039806 [dostęp 2018-07-10].
  • Puneet Anand, Ankur Sachdeva, Effect of Poly Unsaturated Fatty Acids Administration on Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial, „Journal of Clinical and Diagnostic Research : JCDR”, 10 (9), 2016, OC01–OC05, DOI10.7860/JCDR/2016/20423.8471, ISSN 2249-782X, PMID27790483, PMCIDPMC5071983 [dostęp 2018-07-10].
  • Xiang Li i inni, Docosahexanoic Acid-Induced Coronary Arterial Dilation: Actions of 17S-Hydroxy Docosahexanoic Acid on K+ Channel Activity, „The Journal of Pharmacology and Experimental Therapeutics”, 336 (3), 2011, s. 891–899, DOI10.1124/jpet.110.176461, ISSN 0022-3565, PMID21156816, PMCIDPMC3061543 [dostęp 2018-07-10].
  • Timothy J. Key i inni, Long-chain n–3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men, „The American Journal of Clinical Nutrition”, 82 (2), 2005, s. 327–334, DOI10.1093/ajcn/82.2.327, PMID16087975 (ang.).
  • publikacja w otwartym dostępie – możesz ją przeczytać K.M. Appleton, R.C. Hayward, D. Gunnell, T.J. Peters i inni. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. „Am J Clin Nutr”. 84 (6), s. 1308–1316, 2006. DOI: 10.1093/ajcn/84.6.1308. PMID: 17158410. 
  • publikacja w otwartym dostępie – możesz ją przeczytać P.J. Rogers, K.M. Appleton, D. Kessler, T.J. Peters i inni. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. „Br J Nutr”. 99 (2), s. 421–431, 2008. DOI: 10.1017/S0007114507801097. PMID: 17956647. 
  • publikacja w otwartym dostępie – możesz ją przeczytać A.J. Richardson. n-3 Fatty acids and mood: the devil is in the detail. „Br J Nutr”. 99 (2), s. 221–223, 2008. DOI: 10.1017/S0007114507824123. PMID: 17919344. 
  • publikacja w otwartym dostępie – możesz ją przeczytać J. Zhang, Y. Li. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial–comments by Zhang and Li. „Br J Nutr”. 100 (6), s. 1347–1348, 2008. DOI: 10.1017/S0007114508975644. PMID: 18768099. 
  • Gregory A Jicha, William R Markesbery, Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease, „Clinical Interventions in Aging”, 5, 2010, s. 45–61, DOI10.2147/cia.s5231, ISSN 1176-9092, PMID20396634, PMCIDPMC2854051 [dostęp 2018-07-10].

psychologytoday.com

viamedica.pl

journals.viamedica.pl

web.archive.org

worldcat.org

  • Usha Ramakrishnan i inni, Prenatal supplementation with DHA improves attention at 5 y of age: a randomized controlled trial1, „The American Journal of Clinical Nutrition”, 104 (4), 2016, s. 1075–1082, DOI10.3945/ajcn.114.101071, ISSN 0002-9165, PMID27604770, PMCIDPMC5039806 [dostęp 2018-07-10].
  • Puneet Anand, Ankur Sachdeva, Effect of Poly Unsaturated Fatty Acids Administration on Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial, „Journal of Clinical and Diagnostic Research : JCDR”, 10 (9), 2016, OC01–OC05, DOI10.7860/JCDR/2016/20423.8471, ISSN 2249-782X, PMID27790483, PMCIDPMC5071983 [dostęp 2018-07-10].
  • Xiang Li i inni, Docosahexanoic Acid-Induced Coronary Arterial Dilation: Actions of 17S-Hydroxy Docosahexanoic Acid on K+ Channel Activity, „The Journal of Pharmacology and Experimental Therapeutics”, 336 (3), 2011, s. 891–899, DOI10.1124/jpet.110.176461, ISSN 0022-3565, PMID21156816, PMCIDPMC3061543 [dostęp 2018-07-10].
  • Gregory A Jicha, William R Markesbery, Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease, „Clinical Interventions in Aging”, 5, 2010, s. 45–61, DOI10.2147/cia.s5231, ISSN 1176-9092, PMID20396634, PMCIDPMC2854051 [dostęp 2018-07-10].